Biodegradable poly(ether-ester) multiblock copolymers for controlled release applications: An in vivo evaluation

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 1, 2004, Pages 118-127

  Van Dijkhuizen Radersma, R ^a   Roosma, J R ^a   Sohier, J ^a   Peters F L A M A ^b   Van Den Doel, M ^b   Van Blitterswijk, C A ^c   De Groot, K ^c   Bezemer, J M ^a  

^a OctoPlus NV   (Netherlands)

^b IsoTis BV   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Biocompatibility; Cytotoxicity; In vitro degradation; In vivo degradation; Poly(ether ester)

Indexed keywords

BIOCOMPATIBILITY; BUTENES; CELLS; COPOLYMERS; DEGRADATION; ETHERS; HISTOLOGY; HYDROLYSIS; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE; OLIGOMERS; OXIDATION;

FRAGMENTATION; INFLAMMATORY CELLS; POLYMER PARTICLES; POROUS POLYMERS;

BIODEGRADATION;

COPOLYMER; ESTER; POLYETHER; SUCCINIC ACID; TEREPHTHALIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION; HISTOLOGY; HYDROLYSIS; IMPLANT; INFLAMMATION; INTRACELLULAR FLUID; MACROPHAGE; MICROSCOPY; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PHAGOCYTOSIS; POROSITY; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; DELAYED-ACTION PREPARATIONS; ETHERS; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; POLYESTERS; RATS; RATS, WISTAR; SUCCINIC ACID; TIME FACTORS;

EID: 4544315925     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30136     Document Type: Article

References (42)

1. Van Dijkhuizen-Radersma R, Roosma JR, Kaim P, Métairie S, Péters FLAMA, De Wijn J, Zijlstra PG, De Groot K, Bezemer JM. Biodegradable poly(ether-ester) multiblock copolymers for controlled release applications. J Biomed Mater Res 2003. Forthcoming.
2. Bezemer JM, Radersma R, Grijpma DW, Dijkstra PJ, Feijen J, Van Blitterswijk CA. Zero-order release of lysozyme from poly(ethylene glycol)/poly(buthylene terephthalate) matrices. J Control Rel 2000;64:179-192.
3. Bezemer JM, Grijpma DW, Dijkstra PJ, Van Blitterswijk CA, Feijen J. A controlled release system for proteins based on poly(ether ester) block-copolymers: polymer network characterization. J Control Rel 1999;62:393-405.
4. 12 from poly(ethylene glycol)/poly(buthylene terephthalate) multiblock copolymers. Biomaterials 2002;23:1527-1536.
5. Van Dijkhuizen-Radersma R, Wright SJ, Taylor LM, John BA, De Groot K, Bezemer JM. In vitro/in vivo correlation for protein release from poly(ether-ester) microspheres. 2004. Submitted for publication.
6. Van Dijkhuizen-Radersma R, Hesseling SC, Kaim PE, De Groot K, Bezemer JM. Biocompatibility and degradation of poly(ether-ester) microspheres: in vitro and in vivo evaluation. Biomaterials 2002;23:4719-4729.
7. Tracy M, Ward KL, Firouzabadian L, Wang Y, Dong N, Qian R, Zhang Y. Factors affecting the degradation rate of poly(lactideco-glycolide) microspheres in vivo and in vitro. Biomaterials 1999;20:1057-1062.
8. Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989;10:557-563.
9. Menei P, Daniel V, Montero-Menei C, Brouillard M, Poulard-Barthelaix A, Benoit JP. Biodegradation and brain tissue reaction to poly(D,L-lactide-co- glycolide) microspheres. Biomaterials 1993;14:470-478.
10. Lu L, Peter SJ, Lyman MD, Lai HL, Leite SM, Tamade JA, Uyama S, Vacanti JP, Langer R, Mikos AG. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials 2000;21:1873-1845.
11. Mainil-Varlet P, Curtis R, Gogolewski S. Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides. J Biomed Mater Res 1997;36:360-380.
12. Stoll GH, Nimmerfall F, Acemoglu M, Bodmer D, Bantle S, Müller I, Mahl A, Kolopp M, Tullberg K. Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents. J Control Rel 2001;76:209-225.
13. Fulzele SV, Satturwar PM, Dorle AK. Study of the biodegradation and in vivo biocompatibility of novel biomaterials. Eur J Pharm Sci 2003. Forthcoming.
14. Ali SAM, Doherty PJ, Williams DF. Molecular biointeractions of biomedical polymers with extracellular exudates ad inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials 1994;15:779-785.
15. Gogolewski S, Janovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxy acids: Polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHB/VA). J Biomed Mat Res 1993;27:1135-1148.
16. Therin M, Christel P, Li S, Garreau H, Vert M. In vivo degradation of massive poly(α-hydoxy acids): validation of in vitro findings. Biomaterials 1992;13:594-600.
17. Grizzi I, Garreau H, Li S, Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size dependence. Biomaterials 1995;16(4):305-311.
18. Göpferich A, Tessmar J. Polyanhydride degradation and erosion. Adv Drug Del Rev 2002;54:911-931.
19. Lu L, Garcia CA, Mikos AG. In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mat Res 1999;46:236-244.
20. Matlaga BF, Yasenchak LP, Salthouse TN. Issue response to implanted polymers: the significance of sample shape, J Biomed Mater Res 1976;10:391-397.
21. Changez M, Koul V, Krishna B, Dinda AK, Choudhary V. Studies on biodegradation and release of gentamcin sulphate from interpenetrating network hydrogels based on poly(acrylic acid) and gelatin: in vitro and in vivo. Biomaterials 2003. Forthcoming.
22. Deschamps AA, Van Apeldoorn AA, De Bruijn JD, Grijpma DW, Feijen F. Poly(ether ester amide)s for tissue engineering. Biomaterials 2003;24:2643-2652.
23. Suggs LJ, Krishnan RS, Garcia CA, Peter SJ, Anderson JM, Mikos AG. In vitro and in vivo degradation of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mat Res 1998;42:312-320.
24. Montanari L, Costantini M, Ciranni Signoretti E, Valvo L, Santucci M, Bartolomei M, Fattibene P, Onori S, Faucitano A, Conti B, Genta I. Gamma irradiation effects on poly(DL-lactide-co-glycolide) microspheres. J Control Rel 1998;56:219-229.
25. Anderson JM, Langone JJ. Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems. J Control Rel 1999;57;107-113.
26. Anderson JM. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur J Pharm Biopharm 1994;40:1-8.
27. Yamaguchi K, Anderson JM. In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres. J Control Rel 1993;24:81-93.
28. Anderson JA, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Del Rev 1997;28:5-24.
29. Nagata M, Kiyotsukuri T, Takeuchi S, Tsutsumi N, Sakai W. Hydrolytic degradation of aliphatic polyesters copolymerized with poly(ethylene glycol)s. Polym Int 1997;42:33-38.
30. Pitt CG. Non-microbial degradation of polyesters: mechanisms and modifications. In: Vert M, Feijen F, Albertsson A, Scott G, Chiellini, editors. Biodegradable polymers and plastics. Melksham: Redwood Press Ltd; 1992. p 7-17.
31. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1986;17:103-114.
32. Tokiwa Y, Suzuki T. Hydrolysis of copolyesters containing aromatic and aliphatic ester blocks by lipase. J Appl Polym Sci 1981;26:441-448.
33. Reed AM, Gilding DK. Biodegradable polymers for use in surgery poly(ethylene oxide)/poly(ethylene terephthalate) (PEO/PET) copolymers: 2 In vitro degradation. Polymer 1981;22:499-504.
34. Deschamps AA, Grijpma DW, Feijen J. Poly(ethylene oxide)/poly(butylene terephthalate) segmented block copolymers: the effect of copolymer composition on physical properties and degradation behavior. Polymer 2001;42:9335-9345.
35. Nikolic M, Djonlagic J. Synthesis and characterization of biodegradable poly(butylene succinate-co-butylene adipate)s. Polym Degrad Stab 2001;74:263-270.
36. Witt C, Kissel T. Morphological characterization of microspheres, films and implants prepared from poly(lactide-coglycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion. Eur J Pharm Biopharm 2001;51:171-181.
37. Goedemoed JH, Hennink WH, Bezemer JM, Feijen J, Van Blitterswijk CA, De Bruijn JD, inventors. Polyetherester copolymers as drug delivery matrices. European patent 97202533.2. 1998.
38. Deschamps AA, Claase MB, Sleijster MWJ, De Bruijn JD, Grijpma DW, Feijen J. Design of segmented poly(ether ester) materials and structures for tissue engineering of bone. J Control Rel 2002;78:175-86.
39. Deschamps AA. Segmented poly(ether-ester)s and poly(etherester-amide)s for use in tissue engineering [thesis]. Twente, The Netherlands: University of Twente; 2002.
40. Jeong B, Bae YH, Kim SW. In situ gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions and degradation thereof. J Biomed Mat Res 2000;50;171-177.
41. Penco M, Marcioni S, Ferruti P, Dàntone S, Deghenghi R. Degradation behaviour of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. Biomaterials 1996;17:1583-1590.
42. Budavari S, O'Neil MJ, Smith A, Heckelman PE, Kinneary JF, editors. The Merck Index, 12th edition. Whitehouse Station, NJ: Merck & Co; 1996. p 9038, succinic acid; 9306 terephthalic acid.